Filing Details
- Accession Number:
- 0001645113-20-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-15 17:03:29
- Reporting Period:
- 2020-04-13
- Accepted Time:
- 2020-04-15 17:03:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654363 | J. Michael Ambrogi | C/O Novocure Inc. 20 Valley Stream Parkway, Suite 300 Malvern PA 19355 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2020-04-13 | 22,755 | $7.15 | 243,622 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2020-04-13 | 22,755 | $69.01 | 220,867 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2020-04-14 | 35,745 | $7.15 | 256,612 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2020-04-13 | 8,226 | $70.18 | 248,386 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-04-14 | 27,142 | $70.99 | 221,244 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-04-14 | 377 | $71.75 | 220,867 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2020-04-13 | 22,755 | $0.00 | 22,755 | $7.15 |
| Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2020-04-14 | 35,745 | $0.00 | 35,745 | $7.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 80,259 | 2027-02-21 | No | 4 | M | Direct | |
| 44,514 | 2027-02-21 | No | 4 | M | Direct |
Footnotes
- On April 13, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 22,755 shares in multiple trades at prices ranging from $69.00 to $69.42. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 8,226 shares in multiple trades at prices ranging from $69.62 to $70.61. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 27,142 shares in multiple trades at prices ranging from $70.62 to $71.51. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 377 shares in multiple trades at prices ranging from $71.64 to $71.88. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- Fully vested as of the date hereof.
Billionaire Hedge Funds
